アプタマーベースの標的薬物投与と臨床前および臨床応用における疾患治療
Weihong Yang1, Chunyan Ran2, Xinran Lian2
1The Key Laboratory of Zhejiang Province for Aptamers and Theranostics , Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China; Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, Hunan 410082, China.
Advanced drug delivery reviews
|August 31, 2025
まとめ
アプタマーは高度な治療に 精密な標的を設定し 眼疾患,がん,炎症の治療に 有望な効果を示しています このレビューでは,臨床前研究から臨床応用まで,医療におけるその可能性を探ります.
科学分野:
- バイオテクノロジー
- 分子医学
- 薬物投与システム
背景:
- 精密医療には 革新的な薬の標的と投与が必要です
- アプタマーとは,標的に高い親和性と特異性を有するDNAまたはRNA分子である.
- その特性 (安定性,低免疫性,費用対効果) によって,治療に最適です.
研究 の 目的:
- アプタマーベースの治療戦略の最近の進歩をレビューする.
- 直接療法,リガンド工学,制御された放出におけるアプリケーションをカバーする.
- 癌や眼疾患などの病気に対する 臨床前および臨床的なアプタマーの応用を要約します
主な方法:
- アプタマー療法に関する包括的な文献レビュー
- 様々な疾患モデルの臨床前データの分析
- 臨床段階のアプタマー候補の評価とその進展
主要な成果:
- アプタマーは,眼疾患,がん,凝固,炎症に対する臨床前モデルの有効性を示しています.
- いくつかのアプタマー療法が 臨床試験を進めている
- アプタマーの商業化における主要な課題と機会を特定した.
結論:
- アプタマーは有意義な臨床的可能性を持つ標的治療のための多用途のプラットフォームです.
- アプタマーの臨床翻訳における課題を克服するために,さらなる研究と開発が不可欠です.
- アプタマーは 精密医療の将来において 重要な役割を果たすでしょう
関連する概念動画
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Gene Therapy
25.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.8K
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K


